AB1344
Anti-Glucose Transporter GLUT-3 Antibody, CT
serum, Chemicon®
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Productos recomendados
origen biológico
rabbit
Nivel de calidad
forma del anticuerpo
serum
tipo de anticuerpo
primary antibodies
clon
polyclonal
reactividad de especies
rat, mouse
fabricante / nombre comercial
Chemicon®
técnicas
ELISA: suitable
western blot: suitable
Nº de acceso NCBI
Nº de acceso UniProt
Condiciones de envío
wet ice
modificación del objetivo postraduccional
unmodified
Información sobre el gen
mouse ... Slc2A3(20527)
rat ... Slc2A3(25551)
Especificidad
Recognizes Glut-3 in mouse and rat tissues. C terminal peptide used shows no homology to the human sequence.
Inmunógeno
Synthetic peptide corresponding to the C-terminus of mouse Glut-3 coupled to KLH. Product sold sold as AG617
Aplicación
Anti-Glucose Transporter GLUT-3 Antibody, C-terminus is an antibody against Glucose Transporter GLUT-3 for use in ELISA & WB.
Western blotting: 1:1,000-1:5,000, using chemiluminescent detection. Detects a 45-48kDa band in membrane preps from rat brain. Slight differences in band sizes in different tissues; reported range is 45-55kDa.
Other detection methods may require a higher concentration of antibody.
ELISA: 1:10,000 - 1:50,000, using 50-100 ng of antigen/well.
Optimal working dilutions must be determined by end user.
Other detection methods may require a higher concentration of antibody.
ELISA: 1:10,000 - 1:50,000, using 50-100 ng of antigen/well.
Optimal working dilutions must be determined by end user.
Forma física
Liquid rabbit antiserum containing 0.05% sodium azide.
Almacenamiento y estabilidad
Store at -20°C for up to 12 months after date of receipt in undiluted aliquots. Avoid repeated freeze-thaw cycles.
Nota de análisis
Control
The control peptide is available for absorbtion studies. Please see catalog number AG617.
The control peptide is available for absorbtion studies. Please see catalog number AG617.
Información legal
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
¿No encuentra el producto adecuado?
Pruebe nuestro Herramienta de selección de productos.
Código de clase de almacenamiento
10 - Combustible liquids
Clase de riesgo para el agua (WGK)
WGK 1
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Cinzia Dello Russo et al.
The Journal of biological chemistry, 278(8), 5828-5836 (2002-12-18)
Activation of peroxisome proliferator-activated receptors (PPARs) can regulate brain physiology and provide protection in models of neurological disease; however, neither their exact targets nor mechanisms of action in brain are known. In many cells, PPAR gamma agonists increase glucose uptake
C M Cheng et al.
Proceedings of the National Academy of Sciences of the United States of America, 97(18), 10236-10241 (2000-08-24)
The brain has enormous anabolic needs during early postnatal development. This study presents multiple lines of evidence showing that endogenous brain insulin-like growth factor 1 (Igf1) serves an essential, insulin-like role in promoting neuronal glucose utilization and growth during this
Sze Ting Cecilia Kwan et al.
The Journal of nutrition, 147(11), 2083-2092 (2017-09-22)
Background: Fetal growth is dependent on placental nutrient supply, which is influenced by placental perfusion and transporter abundance. Previous research indicates that adequate choline nutrition during pregnancy improves placental vascular development, supporting the hypothesis that choline may affect placental nutrient
Francesca Gaccioli et al.
Biology of reproduction, 89(4), 96-96 (2013-09-06)
The mammalian target of rapamycin (mTOR) and the eukaryotic initiation factor 2 (eIF2) signaling pathways control protein synthesis in response to nutrient availability. Moreover, mTOR is a positive regulator of placental nutrient transport and is involved in the regulation of
Raimund I Herzog et al.
The Journal of clinical investigation, 123(5), 1988-1998 (2013-04-02)
Hypoglycemia occurs frequently during intensive insulin therapy in patients with both type 1 and type 2 diabetes and remains the single most important obstacle in achieving tight glycemic control. Using a rodent model of hypoglycemia, we demonstrated that exposure to
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico